Patents by Inventor Miguel Stevens

Miguel Stevens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF N-AMINOIMIDAZOLE CYTOPROTECTIVE COMPOUNDS FOR TREATING CELL DEATH AND/OR GSK-3 MEDIATED DISEASES
    Publication number: 20120283303
    Abstract: The present invention relates to the use of N-aminoimidazole or N-aminoimidazole thione derivatives as cytoprotective compounds in vitro and in vivo and for the treatment or prevention of cell death mediated disorders and/or GSK-3 mediated disorders or processes.
    Type: Application
    Filed: April 30, 2012
    Publication date: November 8, 2012
    Applicant: K.U.LEUVEN RESEARCH AND DEVELOPMENT
    Inventors: Christophe Pannecouque, Wim Robberecht, Miguel Stevens
  • USE OF N-AMINOIMIDAZOLE CYTOPROTECTIVE COMPOUNDS FOR TREATING CELL DEATH AND/OR GSK-3 MEDIATED DISEASES
    Publication number: 20090149523
    Abstract: The present invention relates to the use of N-aminoimidazole or N-aminoimidazole-thione derivatives as cytoprotective compounds in vitro and in vivo and for the treatment or prevention of cell death mediated disorders and/or GSK-3 mediated disorders or processes.
    Type: Application
    Filed: May 10, 2007
    Publication date: June 11, 2009
    Applicant: K.U.Leuven Research and Development
    Inventors: Christophe Pannecouque, Wim Robberecht, Miguel Stevens